conivaptan has been researched along with topiramate in 1 studies
| Studies (conivaptan) | Trials (conivaptan) | Recent Studies (post-2010) (conivaptan) | Studies (topiramate) | Trials (topiramate) | Recent Studies (post-2010) (topiramate) |
|---|---|---|---|---|---|
| 188 | 17 | 64 | 3,197 | 557 | 1,329 |
| Protein | Taxonomy | conivaptan (IC50) | topiramate (IC50) |
|---|---|---|---|
| Carbonic anhydrase 1 | Homo sapiens (human) | 0.25 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 0.8683 | |
| Carbonic anhydrase 2 | Rattus norvegicus (Norway rat) | 1.4 | |
| Carbonic anhydrase 4 | Bos taurus (cattle) | 0.054 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for conivaptan and topiramate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |